IP Library Patent Application 11198794
Patent Application
App. No. 11/198,794

Cleavage of nucleic acids

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/198,794
Abstract

The present invention relates to means for cleaving a nucleic acid cleavage structure in a site-specific manner. Enzymes, including 5′ nucleases and 3′ exonucleases, are used to detect and identify nucleic acids derived from microorganisms. Methods are provided which allow for the detection and identification of bacterial and viral pathogens in a sample.

Claims (15)

1 - 44 . (canceled)

45 . A composition comprising an isolated FEN-1 endonuclease and an isolated polymerase substantially lacking 5′ nuclease activity.

46 . The composition of claim 45 , wherein said FEN-1 endonuclease and said polymerase are contained in a mixture.

47 . The composition of claim 46 , wherein said mixture comprises a reaction mixture.

48 . The composition of claim 45 , further comprising a nucleic acid molecule.

49 . The composition of claim 48 , wherein said nucleic acid molecule comprises a probe oligonucleotide.

50 . The composition of claim 48 , wherein said nucleic acid molecule is attached to a solid surface.

51 . The composition of claim 45 , further comprising a buffer comprising magnesium.

52 . The composition of claim 45 , further comprising a labeled molecule.

53 . The composition of claim 52 , wherein said labeled molecule comprises a labeled nucleic acid molecule.

54 . The composition of claim 53 , wherein said labeled nucleic acid molecule comprises a fluorescent label.

55 . The composition of claim 45 , further comprising first and second nucleic acid molecules.

56 . The composition of claim 55 , wherein said first and second nucleic acid molecules are both configured to hybridize to a target nucleic acid.

57 . The composition of claim 56 , wherein said first and second nucleic acid molecules are configured to hybridize to a target nucleic acid adjacent to one another.

58 . The composition of claim 45 , wherein said isolated polymerase is from a Thermus species.

Assignments (2)
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
SECURITY AGREEMENT Recorded Jul 29, 2008
From: THIRD WAVE TECHNOLOGIES, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021301/0780 →